Steven Feldman to Metronidazole
This is a "connection" page, showing publications Steven Feldman has written about Metronidazole.
Connection Strength
1.741
-
McGregor SP, Alinia H, Snyder A, Tuchayi SM, Fleischer A, Feldman SR. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea. Dermatol Clin. 2018 Apr; 36(2):135-150.
Score: 0.608
-
Conde JF, Yelverton CB, Balkrishnan R, Fleischer AB, Feldman SR. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol. 2007 May; 6(5):495-8.
Score: 0.291
-
Kirkland CR, Yelverton CB, Fleischer AB, Camacho FT, Feldman SR. Gel vehicles are not inherently more irritating than creams. J Drugs Dermatol. 2006 Mar; 5(3):269-72.
Score: 0.268
-
Ziel K, Yelverton CB, Balkrishnan R, Feldman SR. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. J Drugs Dermatol. 2005 Nov-Dec; 4(6):727-31.
Score: 0.262
-
Davis SA, Feldman SR. Patterns of ambulatory care usage and leading treatments for rosacea. J Dermatolog Treat. 2014 Aug; 25(4):275-7.
Score: 0.120
-
Thomas K, Yelverton CB, Yentzer BA, Balkrishnan R, Fleischer AB, Feldman SR. The cost-effectiveness of rosacea treatments. J Dermatolog Treat. 2009; 20(2):72-5.
Score: 0.082
-
Jayawant SS, Feldman SR, Camacho FT, Yentzer B, Balkrishnan R. Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea. J Dermatolog Treat. 2008; 19(5):267-73.
Score: 0.076
-
Taieb A, Stein Gold L, Feldman SR, Dansk V, Bertranou E. Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States. J Manag Care Spec Pharm. 2016 Jun; 22(6):654-65.
Score: 0.034